Lilly, Gilead, Amgen Started at Outperform by Bernstein
12 Health Care Stocks Moving In Wednesday's After-Market Session
Market Climbs Wednesday, While Morgan Stanley Earnings Beat | Wall Street Today
Spero Therapeutics Presents In Vitro Data At IDWeek 2024 Showing SPR719 Has Low Propensity For Resistance Development In NTM-PD MAC Strains, Highlighting SPR720's Potential For Prolonged Combination Regimens
Indaptus Therapeutics Shares Are Trading Higher. HC Wainwright & Co. Reiterated a Buy Rating on the Stock.
BlackRock In Talks To Deepen Ties With Mukesh Ambani For Private Credit Venture